Micron Earnings Preview Tests AI Memory Shift

Micron earnings due Dec. 16-17, 2025 will test its pivot to AI cloud memory and HBM while traders watch guidance, pricing and options risk.

December 15, 2025·3 min read
View all news articles
Flat filled vector of a server chip merging with stacked memory modules to illustrate Micron earnings pivot.

KEY TAKEAWAYS

  • Micron is scheduled to report fiscal Q1 2026 results for the quarter ended Nov. 2025.
  • Consensus centers near $3.8-$3.9 EPS and $12.5-$12.8 billion revenue, close to company guidance.
  • Investors will focus on management's HBM scale, supply discipline and margin durability commentary.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Micron Technology Inc. (NASDAQ: MU) will report fiscal Q1 2026 results for the quarter ended November 2025 on December 16–17, 2025. The earnings will test whether the company's pivot to AI-focused cloud and data-center memory has reshaped its profitability, as analysts weigh margin durability against execution and valuation risks.

Earnings Timing and Expectations

Micron’s prior-quarter guidance for fiscal Q1 2026 called for revenue of $12.5 billion plus or minus $300 million, non-GAAP EPS of $3.75 plus or minus $0.15, and a gross margin of 51.5% plus or minus 100 basis points. Wall Street consensus aligns closely, expecting EPS around $3.8 to $3.9 and revenue between $12.5 billion and $12.8 billion.

In fiscal Q4 2025, Micron reported revenue of $11.3 billion, up 22% sequentially and 46% year over year, with a consolidated gross margin of 45.7%, a 670-basis-point increase from the prior quarter. Analysts attribute these gains to stronger pricing and a richer mix favoring high-bandwidth memory (HBM) and data-center products.

AI Memory Mix and Market Drivers

Micron is shifting its focus from mobile and consumer memory toward higher-margin cloud and data-center memory and HBM. Analyst models estimate the Cloud Memory segment carries about a 59% gross margin and 48% operating margin. Data-center shipments now represent roughly 56% of Micron’s volume, with an estimated 52% gross margin, well above the company’s historical 30% to 40% margin range.

HBM revenue is estimated at about $2 billion per quarter, or $8 billion annualized. The ramp-up of HBM3E production is tightening DRAM wafer capacity and supporting pricing across DRAM products.

Sector commentary describes a rebound in DRAM and NAND pricing into late 2025, driven by AI and data-center demand outpacing supply. Contract DDR prices are projected to rise about 35% quarter over quarter in Q4 2025, with NAND prices up roughly 20% in the same period. Some forecasts expect DRAM undersupply to persist into 2027 and NAND tightness through 2026 without significant new capacity.

Capital expenditures among the three major memory suppliers—Micron, Samsung, and SK hynix—total about $54 billion in 2025, focused on advanced memory like HBM and leading-edge DRAM nodes rather than commodity PC DRAM. Micron has reduced its consumer DRAM footprint, winding down the Crucial brand, and announced a $9.6 billion investment in a new HBM facility in Hiroshima, Japan, with shipments planned to start in 2028.

Analysts highlight capital discipline as a key variable. Micron has previously indicated near-term capex around $18 billion, which, if pursued aggressively, could raise concerns about future oversupply.

Market sentiment is mixed ahead of the earnings. Wedbush raised its 12-month price target to $300 with an Outperform rating, while another bullish analysis supports a $311 target based on a roughly 10.18x enterprise-value-to-adjusted-EBITDA multiple on estimated fiscal 2027 results. Conversely, at least one preview downgraded the stock to Hold, citing the roughly 186.5% year-to-date rally and high expectations. Options markets imply a roughly 10% move around the Q1 report, reflecting elevated event risk and divergent views.

The upcoming earnings report is widely seen as the most significant test yet of Micron’s re-rating. Beyond headline numbers, investors will focus on management’s commentary regarding multi-year visibility into HBM and DRAM demand, supply discipline, and pricing sustainability.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Google Real-Estate Ad Test Sends Zillow Tumbling

Google Real-Estate Ad Test Sends Zillow Tumbling

Google real-estate ad test put homes-for-sale at the top of mobile Search, coinciding with a Zillow stock plunge and pressuring portal leads.

ServiceNow Armis Acquisition Sends Shares Lower

ServiceNow Armis Acquisition Sends Shares Lower

ServiceNow Armis acquisition reports and a KeyBanc downgrade pressured shares, raising near-term trading risk and fueling debate over M&A versus AI focus.

Luminar Bankruptcy Enables $110 Million Semiconductor Sale

Luminar Bankruptcy Enables $110 Million Semiconductor Sale

Luminar bankruptcy starts court-supervised sales and a $110M semiconductor deal; traders will watch section 363 auction, creditor backing and cash runway.

Fed Chair Candidates Warsh Leads as Hassett Faces Pushback

Fed Chair Candidates Warsh Leads as Hassett Faces Pushback

Fed chair candidates Warsh led prediction markets after Trump's shortlist, and Hassett stressed Fed independence amid pushback, shifting trader odds.

Tesla Robotaxi Testing in Austin

Tesla Robotaxi Testing in Austin

Tesla robotaxi testing in Austin began after a Dec. 14, 2025 video and CEO confirmation, prompting investor reweighting and heightened regulatory scrutiny.

Sanofi Tolebrutinib FDA Delay And PPMS Trial Failure

Sanofi Tolebrutinib FDA Delay And PPMS Trial Failure

Sanofi tolebrutinib faces a U.S. FDA delay for nrSPMS and a failed Phase 3 PPMS trial, prompting expanded access and an impairment test before Q4 results.